{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:39:57Z","timestamp":1780555197665,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-17-C-0019"],"award-info":[{"award-number":["HDTRA1-17-C-0019"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41 GM103403"],"award-info":[{"award-number":["P41 GM103403"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-617"],"award-info":[{"award-number":["NR-617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-616"],"award-info":[{"award-number":["NR-616"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-618"],"award-info":[{"award-number":["NR-618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009898","name":"Defense Health Agency","doi-asserted-by":"publisher","award":["W81XWH-07-2-0067"],"award-info":[{"award-number":["W81XWH-07-2-0067"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.str.2023.11.015","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T10:26:05Z","timestamp":1703759165000},"page":"131-147.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain"],"prefix":"10.1016","volume":"32","author":[{"given":"Rajeshwer S.","family":"Sankhala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dussupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis A.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Hajduczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misook","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer L.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Swafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Kuklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Soman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Corbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Zemil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letzibeth","family":"Mendez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Townsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina C.","family":"Donofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri G.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"de Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Gromowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Paquin-Proulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewald","family":"van Dyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh Ming","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"McTamney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly J.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gordon","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2023.11.015_bib1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.str.2023.11.015_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02590-20","article-title":"Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals","volume":"11","author":"Beaudoin-Bussi\u00e8res","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.str.2023.11.015_bib3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.str.2023.11.015_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.str.2023.11.015_bib5","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1038\/s41467-021-23473-6","article-title":"Immune response to SARS-CoV-2 variants of concern in vaccinated individuals","volume":"12","author":"Becker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2023.11.015_bib6","doi-asserted-by":"crossref","first-page":"n579","DOI":"10.1136\/bmj.n579","article-title":"Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012\/1: matched cohort study","volume":"372","author":"Challen","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.str.2023.11.015_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg3055","article-title":"Estimated Transmissibility and Impact of SARS-CoV-2 Lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","article-title":"Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7","volume":"593","author":"Davies","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib9","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2468-2667(21)00073-6","article-title":"Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages","volume":"6","author":"Jewell","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.str.2023.11.015_bib10","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.str.2023.11.015_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"Volz","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib12","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","volume":"184","author":"Zhou","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.str.2023.11.015_bib13","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.str.2023.11.015_bib14","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jmv.27541","article-title":"OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear","volume":"94","author":"Thakur","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.str.2023.11.015_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s42003-023-04687-4","article-title":"Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron","volume":"6","author":"Burkholz","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/JS9.0000000000000246","article-title":"The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1 and XBB1.5 are expanding rapidly with unique mutations, antibody evasion and immune escape properties- an alarming global threat of surge in COVID-19 cases again?","volume":"109","author":"Chakraborty","year":"2023","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.str.2023.11.015_bib17","series-title":"\u201cClassification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern\u201d","year":"2021"},{"key":"10.1016\/j.str.2023.11.015_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110143","article-title":"SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity","volume":"37","author":"Joyce","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.str.2023.11.015_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03817-4","article-title":"Broad sarbecovirus neutralization by a human monoclonal antibody","volume":"597","author":"Tortorici","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.abf4830","article-title":"Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody","volume":"371","author":"Rappazzo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00284-022-03003-3","article-title":"Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development","volume":"79","author":"Pandey","year":"2022","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.str.2023.11.015_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204256119","article-title":"The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2","volume":"119","author":"Xiong","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2023.11.015_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.str.2023.11.015_bib27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.str.2023.11.015_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.abi6226","article-title":"Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity","volume":"373","author":"Gobeil","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41594-020-0479-4","article-title":"Controlling the SARS-CoV-2 spike glycoprotein conformation","volume":"27","author":"Henderson","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001237","article-title":"Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies","volume":"19","author":"Zhu","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.str.2023.11.015_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.abh1766","article-title":"Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants","volume":"373","author":"Wang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","volume":"29","author":"Cerutti","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.str.2023.11.015_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.str.2023.11.015_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03720-y","article-title":"In\u00a0vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains","volume":"596","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib38","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.str.2023.11.015_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41467-020-20501-9","article-title":"Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry","volume":"12","author":"Ge","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2023.11.015_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41422-021-00490-0","article-title":"Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2","volume":"31","author":"Yan","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.str.2023.11.015_bib41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41594-020-0468-7","article-title":"SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects","volume":"27","author":"Wrobel","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib42","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib43","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1093\/cid\/ciab1041","article-title":"Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients","volume":"75","author":"Lu","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.str.2023.11.015_bib44","article-title":"mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant","volume":"3","author":"Edara","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.str.2023.11.015_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.str.2023.11.015_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jviromet.2005.03.021","article-title":"Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins","volume":"128","author":"Tripp","year":"2005","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.str.2023.11.015_bib47","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.str.2023.11.015_bib48","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2023.11.015_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02002-17","article-title":"Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape","volume":"92","author":"Wang","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2023.11.015_bib50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.str.2023.11.015_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009089","article-title":"A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody","volume":"16","author":"Wu","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.str.2023.11.015_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.chom.2020.06.010","article-title":"Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.str.2023.11.015_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jviromet.2005.03.021","article-title":"Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins","volume":"128","author":"Tripp","year":"2005","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.str.2023.11.015_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s42003-017-0006-2","article-title":"Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies","volume":"1","author":"Rajan","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib55","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41590-021-01068-z","article-title":"Low-dose in\u00a0vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations","volume":"22","author":"Dussupt","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.str.2023.11.015_bib56","doi-asserted-by":"crossref","first-page":"eabi5735","DOI":"10.1126\/scitranslmed.abi5735","article-title":"A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates","volume":"14","author":"Joyce","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.str.2023.11.015_bib57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.abh2315","article-title":"Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study","volume":"374","author":"Hastie","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01596-22","article-title":"Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity","volume":"97","author":"Jensen","year":"2023","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2023.11.015_bib59","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cell.2021.02.026","article-title":"Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection","volume":"184","author":"Winkler","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.str.2023.11.015_bib60","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in\u00a0vivo","volume":"218","author":"Sch\u00e4fer","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.str.2023.11.015_bib61","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.immuni.2021.08.015","article-title":"Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy","volume":"54","author":"Ullah","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.str.2023.11.015_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678570","article-title":"Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses","volume":"12","author":"Bullen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.str.2023.11.015_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib64","article-title":"Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift","author":"Song","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.str.2023.11.015_bib65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.str.2023.11.015_bib66","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.str.2023.11.015_bib67","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib68","article-title":"Coronaviruses with a SARS-CoV-2-like receptorbinding domain allowing ACE2-mediated entry into human cells isolated from bats of Indochinese peninsula","author":"Temmam","year":"2021","journal-title":"Research Square"},{"key":"10.1016\/j.str.2023.11.015_bib69","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1128\/JVI.02582-15","article-title":"Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus","volume":"90","author":"Yang","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2023.11.015_bib70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.str.2023.11.015_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006698","article-title":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus","volume":"13","author":"Hu","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.str.2023.11.015_bib72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jcim.1c01451","article-title":"Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance","volume":"62","author":"Chen","year":"2022","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.str.2023.11.015_bib73","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.str.2023.11.015_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01674-18","article-title":"Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope","volume":"9","author":"West","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.str.2023.11.015_bib75","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","article-title":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion","volume":"176","author":"Walls","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.str.2023.11.015_bib76","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural basis for broad coronavirus neutralization","volume":"28","author":"Sauer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib78","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114544","article-title":"Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody","volume":"13","author":"Li","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.str.2023.11.015_bib79","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1038\/s41467-021-25997-3","article-title":"Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2023.11.015_bib80","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.str.2023.11.015_bib81","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molcel.2016.06.012","article-title":"Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability","volume":"63","author":"Goldenzweig","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2023.11.015_bib82","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2023.11.015_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-59745-554-1_2","article-title":"Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery","volume":"525","author":"Chan","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib84","series-title":"BUSTER","author":"Bricogne","year":"2017"},{"key":"10.1016\/j.str.2023.11.015_bib85","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01456","article-title":"Collaboration gets the most out of software","volume":"2","author":"Morin","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.str.2023.11.015_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007056","article-title":"The\u00a0breadth of HIV-1 neutralizing antibodies depends on the conservation\u00a0of key sites in their epitopes","volume":"15","author":"Bai","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.str.2023.11.015_bib87","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1145\/235815.235821","article-title":"The quickhull algorithm for convex hulls","volume":"22","author":"Barber","year":"1996","journal-title":"ACM Trans. Math. Softw."},{"key":"10.1016\/j.str.2023.11.015_bib88","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/bioinformatics\/btg299","article-title":"PDB file parser and structure class implemented in Python","volume":"19","author":"Hamelryck","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.str.2023.11.015_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2018.08.012","article-title":"A flow cytometry based assay that simultaneously\u00a0measures cytotoxicity and monocyte mediated antibody\u00a0dependent effector activity","volume":"462","author":"Alrubayyi","year":"2018","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.str.2023.11.015_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.016","article-title":"A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples","volume":"366","author":"Ackerman","year":"2011","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212623004409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212623004409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:42:37Z","timestamp":1778575357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212623004409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0969212623004409"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2023.11.015","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2023.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}